The global albuterol sulfate inhalation solution market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The global market is growing due to the increasing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease. According to World Health Organization in May 2021, Asthma has affected 262 million people in 2019 and caused 461,000 deaths globally. Asthma almost affects almost 5%-10% of the global population that accounts for 23.4 million people including 7 million children. The demand for albuterol sulfate inhalation solution has increased substantially during the COVID-19 pandemic as doctors were prescribing this drug for the treatment of COVID-19 patients having breathing and respiratory problems. Additionally, the presence of key manufacturing companies and huge investment in research and development activities is boosting the growth of the global albuterol sulfate inhalation solution market in the forecast period.
(Get 15% Discount on Buying this Report)
A full report is available at : https://orionmarketreports.com/global-albuterol-sulfate-inhalation-solution/92778/
For instance, In January 2022, US Food and Drug Administration approved new drug application named ANDA 214531 to The Ritedose Corp. for Albuterol Sulfate Inhalation Solution in 2 variants, 0.63 mg /3 mL and 1.25 mg/3 mL for the treatment of asthma in patients of 2 to 12 years of age.
Market Coverage
The market number available for – 2022-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
Rest of the World
Competitive Landscape– Merck & Co., Inc., GlaxoSmithKline plc. , Teva Pharmaceutical Industries Ltd. among others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are playersaddressing challenges to sustain growth?
- Where is the investment opportunity?
Global Albuterol Sulfate Inhalation Solution Market Report by Segment
By Type
- Albuterol Sulfate Inhalation Aerosol90 mcg
- Albuterol Sulfate Inhalation Aerosol108 mcg
- Albuterol Sulfate Inhalation Aerosol120 mcg
By Application
- Albuterol Sulfate Inhalation Solution 0.083%
- Albuterol Sulfate Inhalation Solution 0.042%
- Albuterol Sulfate Inhalation Solution 0.021%
- Albuterol Sulfate Inhalation Solution 0.5%
By Distribution Channel
- Hospitals
- Drug Stores
- Others
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name : Orion Market Reports
Contact Person : Mr. Anurag Tiwari
Email : Info@orionmarketreports.com
Contact No : +91 780-304-0404
This release has been published on Global market Post
Global market Post is not responsible for any content included in this release.
